Publications



Dysregulated lipid metabolism in colorectal cancer


Coleman, O., Ecker, M., Haller, D. (2022). Curr Opin Gastroenterol 38, 162-167.

DOI:10.1097/MOG.0000000000000811

The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner


Meinhardt, A.L., Munkhbaatar, E., Hockendorf, U., Dietzen, M., Dechant, M., Anton, M., Jacob, A., Steiger, K., Weichert, W., Brcic, L., McGranahan, N., Branca, C., Kaufmann, T., Dengler, M.A., Jost, P.J. (2022). Oncogene

DOI:10.1038/s41388-021-02161-1

Initial evaluation of [(18)F]-FACBC for PET imaging of multiple myeloma


Morath, V., Heider, M., Mittelhauser, M., Rolbieski, H., Stroh, J., Calais, J., Eiber, M., Bassermann, F., Weber, W.A. (2022). EJNMMI Res 12, 4.

DOI:10.1186/s13550-022-00876-0

Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?


Herz, A.L., Wisser, S., Kohlruss, M., Slotta-Huspenina, J., Jesinghaus, M., Grosser, B., Steiger, K., Novotny, A., Hapfelmeier, A., Schmidt, T., Gaida, M.M., Weichert, W., Keller, G. (2022). J Pathol Clin Res.

DOI:10.1002/cjp2.257

A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-kappaB signaling in activated T cells


Yin, H., Karayel, O., Chao, Y.Y., Seeholzer, T., Hamp, I., Plettenburg, O., Gehring, T., Zielinski, C., Mann, M., Krappmann, D. (2022). Cell Mol Life Sci 79, 112.

DOI:10.1007/s00018-022-04154-z

Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency


Sefer, A.P., Abolhassani, H., Ober, F., Kayaoglu, B., Bilgic Eltan, S., Kara, A., Erman, B., Surucu Yilmaz, N., Aydogmus, C., Aydemir, S., Charbonnier, L.M., Kolukisa, B., Azizi, G., Delavari, S., Momen, T., Aliyeva, S., Kendir Demirkol, Y., Tekin, S., Kiykim, A., Baser, O.F., Cokugras, H., Gursel, M., Karakoc-Aydiner, E., Ozen, A., Krappmann, D., Chatila, T.A., Rezaei, N., Baris, S. (2022). J Clin Immunol.

DOI:0.1007/s10875-021-01191-4

MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer


Lee, J.L., Ekambaram, P., Carleton, N.M., Hu, D., Klei, L.R., Cai, Z., Myers, M.I., Hubel, N.E., Covic, L., Agnihotri, S., Krappmann, D., Bornancin, F., Lee, A.V., Oesterreich, S., McAllister-Lucas, L.M., Lucas, P.C. (2021). Mol Cancer Res.

DOI:10.1158/1541-7786.MCR-21-0208

Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma


Schick, M., Zhang, L., Maurer, S., Maurer, H.C., Isaakaidis, K., Schneider, L., Patra, U., Schunck, K., Rohleder, E., Hofstetter, J., Baluapuri, A., Scherger, A.K., Slotta-Huspenina, J., Hettler, F., Weber, J., Engleitner, T., Maresch, R., Slawska, J., Lewis, R., Istvanffy, R., Habringer, S., Steiger, K., Baiker, A., Oostendorp, R.A.J., Miething, C., Lenhof, H.P., Bassermann, F., Chapuy, B., Wirth, M., Wolf, E., Rad, R., Muller, S., Keller, U. (2022). Nat Commun 13, 281.

DOI:10.1038/s41467-021-27704-8

Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling


Zecha, J., Gabriel, W., Spallek, R., Chang, Y.C., Mergner, J., Wilhelm, M., Bassermann, F., Kuster, B. (2022). Nat Commun 13, 165.

DOI:10.1038/s41467-021-27639-0

Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression


Rauca, V.F., Patras, L., Luput, L., Licarete, E., Toma, V.A., Porfire, A., Mot, A.C., Rakosy-Tican, E., Sesarman, A., Banciu, M. (2021). Sci Rep 11, 22102.

DOI:10.1038/s41598-021-01284-5